Slide 1: 2021 full-year report
2021 full-year report Webcast for investors, analysts and media Basel, February 15, 2022 1 Disclaimer This presentation contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause a
Slide 2: Agenda
Agenda Highlights Guillaume Daniellot Business & regional review Peter Hackel Recent achievements & strategy in action Guillaume Daniellot Outlook 2022 Guillaume Daniellot Guillaume Daniellot Q&A and upcoming events Peter Hackel 3 Highlights Guillaume Daniellot, CEO 4 2
Slide 3: Group celebrates CHF 2 billion revenue
Group celebrates CHF 2 billion revenue REVENUE CORE PROFITABILITY SMILES 2.022 billion EBIT margin 27.4% 3.7 million +41.7% organic growth1 in 2021 IFRS EBIT margin 26.8% Ambition: 10 million smiles per year by 2030 CHF 540m revenue in Q4 +21.1% organic growth1 in Q4 MARKET SHARE GAINS CULTURE OUTLO
Slide 4: Business and regional review
Investing in people to further capture opportunities Employees Straumann Group employees in Curitiba, Brazil 7 7 Business and regional review Peter Hackel, CFO 8 4
Slide 5: Strong revenue growth in 2021
Strong revenue growth in 2021 Revenue development (in CHF million, rounded) Regional share of 41.8% organic growth in CHF 41.7% organic Change in organic growth 41.3% 40.0% 40.6% 56.8% 9 9 EMEA and North America report strong growth EMEA Revenue change (organic) Germany, UK, France, Spain 56% 101.
Slide 6: Asia Pacific and Latin America show strong growth
Asia Pacific and Latin America show strong growth Asia Pacific Revenue change (organic) 74.4% Increased market share led by 56% 62.8% China, Japan and Australia Premium and challenger 28.5% 20% of Group* 24.5% 11.0% 17.9% 17.0% implant brands drive growth, challengers growing faster Q4 Q1 Q2 Q3
Slide 7: Core financials at a glance
The following effects were defined as non-core items 2021 Amortization of acquisition-related intangible assets amounting to CHF 8 million Earn-out provision of CHF 49 million payable to the sellers of DrSmile 2020 Amortization of acquisition-related intangible assets of CHF 9 million Impair
Slide 8: Reported financials and core results reconciliation
Reported financials at a glance % of Margin Change In CHF million, rounded FY 2021 Comments revenue change in % Revenue 2’022 41.8% COGS (482) 23.8%placeholder 21.7% GROSS PROFIT 1’540 76.2% 395bps FX headwind -20bps Operating expenses (997) 49.3% (14.2%) Incl. short-time allowance in 2020 EBIT 543
Slide 9: Core gross margin above 76%
Core gross margin above 76% In %, rounded 340bps 360bps 76.2 17 17 Core EBIT margin at 27.4% In %, rounded 400bps 450bps t/o 1070bps impairments 18 18 9
Slide 10: Core net profit margin and free cash flow
Core net profit margin improved to almost 23% In CHF million, rounded thereof CHF 150m impairments Net profit Net profit margin margin 18.3% 22.6% 19 19 High free cash flow Operating cash flow In CHF million Y/Y change In CHF million, rounded FY 2020 377 FY 2021 560 +49% 110bps FCF margin FCF margin
Slide 11: Investing in the future; higher dividend and share split
Investing in the future 2021 decisions to invest more than CHF 300m in the coming years For example Group Technology and Innovation Center, China Campus Arlesheim, CH in Shanghai CHF 18m CHF 170m CADCAM and milling manufacturing site in Mansfield, US CHF 46m 21 21 Higher dividend and share split pro
Slide 12: Recent achievements & strategy in action
Recent achievements & strategy in action Guillaume Daniellot, CEO 23 Purpose, vision and sharpened culture architecture Purpose: We exist… To unlock the potential of people’s lives Vision: We believe in … A world where oral health is a source of confidence 24 24 12
Slide 13: Culture journey in 2021
Culture journey in 2021 – sharpened beliefs We are bold and big in our thinking. We strive for true impact through Our entrepreneurial mindsets give us progress, not perfection, as the courage to seize opportunities. speed matters in our business. We empower and inspire everyone around We are accoun
Slide 14: Mission and evolved strategy
Mission and evolved strategy Mission: Our goal is to be … The most customer focused and innovative oral care company in the world 27 27 Innovation in premium implantology immediacy • BLX implant received regulatory Premium implant market – 8 million implants approval in China • BLX launched in Russi
Slide 15: Challenger brands gaining share in value segment
Challenger brands gaining share in value segment with geographical expansion Multi-brand strategy Value implant market – 24 million implants 1 Geographical expansion EMEA NAM • Neodent in more than 80 countries • Anthogyr launched in Saudia Arabia, Qatar, Russia, South Korea • Medentika and Anthogyr
Slide 16: Strengthened orthodontics value proposition
Strengthened orthodontics value proposition and ongoing geographical expansion Strong value proposition Geographical expansion • Software launches well received – ClearPilot • Connectivity with intraoral scanners – high adoption with close to 90% of case starts submitted digitally by clinicians 3 ma
Slide 17: Developing consumer presence in implantology; sustainability framework
Developing consumer presence in implantology Nihon Implant acquired: signed agreement in December, closed in January 2022 Founded in 2013, a leading implant treatment concierge in Japan Connects patients with clinicians, referring patients for implant high-quality treatment to specialty clinic
Slide 18: Outlook 2022
Outlook 2022 35 Outlook 2022 In 2022, patient flow is not expected to be significantly impacted by the pandemic should the situation remain stable Market Trying to anticipate and mitigate potential supply chain disruption, environment inflationary and geopolitical developments and their potentia
Slide 19: Questions & answers
Questions & answers Q&A 37 38 38 19
Slide 20: Calendar of upcoming events; currency exposure
Calendar of upcoming events 2022 Event Location 16-18 February North America Roadshow (Bank of America) Virtual 23, 25 February European Roadshow (Credit Suisse) Virtual 16 – 17 March Roadshow Paris and London 23 – 24 March Roadshow Frankfurt and Amsterdam 5 April Annual General Meeting 28 April Fir
Slide 21: Thank you
Thank you 41 21